Anna McCaughna
Family · Ft Myers, FLNPI 1649248493
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,993 of the $4,449 with a category attached, or 89.8%. It is spread thinly across 23 manufacturers, the largest accounting for just 11.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,565, more than ten times the $151 reported in 2022. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 214 payments — averaging $20.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$504
- Amgen$460
- AbbVie$443
- Sanofi$413
- E.r. Squibb & Sons, L.L.C.$412
- Lilly USA, LLC$312
- plus $2K from 17 others
What the payments were for
- Food & beverage$3,99390%
- Education$45610%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 18 | $504 |
| Amgen | 21 | $460 |
| AbbVie | 25 | $443 |
| Sanofi | 18 | $413 |
| E.r. Squibb & Sons, L.L.C. | 20 | $412 |
| Lilly USA, LLC | 17 | $312 |
| Novartis | 31 | $237 |
| UCB, Inc. | 6 | $182 |
| Sun Pharmaceutical Industries Inc. | 10 | $178 |
| Boehringer Ingelheim | 6 | $167 |
| Arcutis Biotherapeutics, Inc. | 4 | $159 |
| Sanofi-aventis U.S. LLC | 2 | $157 |
| Regeneron Healthcare Solutions, Inc. | 6 | $144 |
| LEO Pharma Inc. | 5 | $142 |
| Incyte Corporation | 6 | $136 |
| Pfizer | 7 | $134 |
| Organon | 6 | $78 |
| Convatec Inc. | 1 | $56 |
| Kerecis Limited | 1 | $41 |
| Genentech USA, Inc. | 1 | $33 |
| Almirall LLC | 1 | $22 |
| Galderma Laboratories, L.p. | 1 | $21 |
| LNHC, Inc | 1 | $18 |
How this compares
$4,449 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 47 | $178,298 |
| Fluorouracil | 49 | $3,099 |
| CiclopiroxCiclopirox Olamine | 55 | $1,679 |
| Metronidazole | 13 | $1,449 |
| Clobetasol Propionate | 17 | $416 |
| Triamcinolone Acetonide | 51 | $345 |
| Ketoconazole | 20 | $287 |
| Doxycycline Hyclate | 14 | $207 |
| Cephalexin | 13 | $136 |
Paid to pharmacies, not to this prescriber.
Other family in Ft Myers
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.